Esophageal Cancer, Gastric Cancer, Pancreatic Cancer
Conditions
Keywords
Frailty, Prehabilitation
Brief summary
A one-group prospective cohort study design with measures collected pre- and post-intervention. The primary goal of this study is to evaluate the effect of a multimodal prehabilitation preoperative program on changes in frailty in upper gastrointestinal surgical oncology patients.
Detailed description
Cancer patients often develop protein calorie malnutrition, inflammatory states, and loss of lean muscle mass, which can be best categorized as frailty. Frailty affects global health, the ability to carry out normal functions, and even the ability to tolerate targeted curative treatments such as surgery, chemotherapy, and radiation. The Investigators evaluate frailty, and design a study to evaluate the outcomes of the administration of multimodal preoperative prehabilitation programs on those frailty markers. Previous data provides support for interventions that include: 1. Improved protein rich nutrition with specific immunonutrition recommendations, 2. Treatment of maldigestion or pancreatic insufficiency in pancreatic, gastric, or esophageal cancer patients, 3. Brief, evidence-based activity interventions such as walking and inspiratory muscle training (IMT), and 4. Disease specific education These interventions should improve frailty by maintaining or regaining weight, improved grip strength, and improved prealbumin. These markers indicate improvements in nutritional status, increased strength and ability to ambulate, and improved functional status in the preoperative period. Other outcomes that will be reported include fat-soluble vitamin levels, global health, and inflammation. The preoperative period is the best time to facilitate patient engagement through self-care and proactive activity. Interventions must be easy to accomplish and structured so patients have accountability and both patients and clinicians have methods and tools for measuring progress. Most patients and family members are motivated at this time and understand the need to improve frailty and potentially improve global health.
Interventions
COMBINATION_PRODUCTNutritional Intervention
Nutritional Supplementation for all subjects and Pancreatic Enzyme Replacement Therapy only for subjects with Exocrine Pancreatic Insufficiency
BEHAVIORALPhysical Activity Intervention
Walking and Inspiratory Muscle Training
Sponsors
Siobhan Trotter
Study design
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
25 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
* All patients must be patients of Ochsner being seen at the Ochsner Medical Center (OMC). * All patients must be 25 to 80 years of age. * All patients must have a diagnosis of cancer. * \> 10 pound unintentional weight loss within 1 year * Ability to perform grip strength test and Timed Up and Go (TUG) test * Willingness to participate in the study, document compliance, and attend clinical appointments * All patients must be undergoing one of the following major elective surgical oncologic resections with curative intent: * Pancreaticoduodenectomy for pancreatic cancer * Distal pancreatectomy / splenectomy for pancreatic cancer * Esophageal robotic assisted laparoscopic thoracoscopic esophagectomy for esophageal cancer * Laparoscopic or open, partial or total gastrectomy for gastric cancer
Exclusion criteria
* All patients not undergoing oncologic or major resections. * All patients unwilling or unable to answer questionnaires or accept help to answer electronic or paper questionnaires. * All patients that are unable to participate in an activity program. * All patients unable to wear an electronic activity monitoring device. * All patients not wanting to follow a specific nutritional and breathing intervention. * All patients that are not able or wishing to consent.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Frailty Measurement | 4 Weeks | Frailty will be measured using 3 criteria: weight loss, grip strength, and prealbumin serum level |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Vitamin levels | 4 Weeks | — |
| Quality of Life (QoL) Assessment | 4 Weeks | QoL will be assessed using Patient-Reported Outcome Measurement Information System (PROMIS) Global Health Questionnaire - PROMIS Scale v1.2 - Global Health |
Countries
United States
Outcome results
None listed